株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

粒子治療市場:世界の業界分析、規模、シェア、成長、動向、予測(2018〜2026年)

Particle Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

発行 Transparency Market Research 商品コード 799167
出版日 ページ情報 英文 230 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.00円で換算しております。
Back to Top
粒子治療市場:世界の業界分析、規模、シェア、成長、動向、予測(2018〜2026年) Particle Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
出版日: 2019年02月06日 ページ情報: 英文 230 Pages
概要

粒子治療を除く多数のがん患者、高齢者における脳腫瘍発症件数の増加が、プロトン、炭素を使用した治療を普及させています。痛みが少なく高解像度の治療技術であることが世界の粒子治療の拡大を推進しています。

当レポートでは、世界の粒子治療市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 序論

第2章 仮定と調査方法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会
  • 市場分析と予測
  • 市場見通し
  • 法規制シナリオ
  • 臨床における粒子治療施設
  • 価格分析

第5章 治療別市場分析と予測

  • イントロダクションと定義
  • 調査結果と動向
  • 市場予測
    • プロトン
    • 炭素
    • その他
  • 市場の魅力度

第6章 癌別市場分析と予測

  • イントロダクションと定義
  • 調査結果と動向
  • 市場予測
    • 小児癌
    • 肺癌
    • 膀胱癌
    • 脳腫瘍・脊椎腫瘍
    • 乳癌
    • 消化器癌
    • 肝細胞癌
    • 頭頸部癌
    • その他
  • 市場の魅力度

第7章 サービス別市場分析と予測

  • イントロダクションと定義
  • 調査結果と動向
  • 市場予測
    • サイクトロトン
    • シンクロトロン
    • シンクロサイクトロトン
  • 市場の魅力度

第8章 エンドユーザー別市場分析と予測

  • イントロダクションと定義
  • 調査結果と動向
  • 市場予測
    • 病院
    • 専門クリニック
    • 外来外科センター
    • その他
  • 市場の魅力度

第9章 地域別市場分析と予測

  • 主な調査結果
  • 市場予測
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力度

第10章 北米市場

第11章 欧州市場

第12章 アジア太平洋地域市場

第13章 ラテンアメリカ市場

第14章 中東・アフリカ市場

第15章 競合環境

  • 参入企業:競合マトリクス
  • 市場シェア分析
  • 企業プロファイル

図表

図表

List of Tables

  • Table 01: Global Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2016-2026
  • Table 02: Global Particle Therapy Market Value (US$ Mn) Forecast, by Cancer Application, 2016-2026
  • Table 03: Global Particle Therapy Market Value (US$ Mn) Forecast, by Services, 2016-2026
  • Table 04: Global Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 05: Global Particle Therapy Market Value (US$ Mn) Forecast, by Region, 2016-2026
  • Table 06: North America Particle Therapy Market Value (US$ Mn) Forecast, by Country, 2016-2026
  • Table 07: North America Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2016-2026
  • Table 08: North America Particle Therapy Market Value (US$ Mn) Forecast, by Services, 2016-2026
  • Table 09: North America Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 10: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 11: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2016-2026
  • Table 12: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Services, 2016-2026
  • Table 13: Europe Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 14: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Cancer Application, 2016-2026
  • Table 15: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 16: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2016-2026
  • Table 17: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Services, 2016-2026
  • Table 18: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 19: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Cancer Application, 2016-2026
  • Table 20: Latin America Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 21: Latin America Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2016-2026
  • Table 22: Latin America Particle Therapy Market Value (US$ Mn) Forecast, by Services, 2016-2026
  • Table 23: Latin America Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 24: Latin America Particle Therapy Market Value (US$ Mn) Forecast, by Cancer Application, 2016-2026
  • Table 25: Middle East & Africa Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 26: Middle East & Africa Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2016-2026
  • Table 27: Middle East & Africa Particle Therapy Market Value (US$ Mn) Forecast, by Services, 2016-2026
  • Table 28: Middle East & Africa Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 29: Middle East & Africa Particle Therapy Market Value (US$ Mn) Forecast, by Cancer Application, 2016-2026

List of Figures

  • Figure 01: Global Particle Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016-2026
  • Figure 02: Global Particle Therapy Market Value Share, by Cancer Application, 2017
  • Figure 03: Global Particle Therapy Market Value Share, by Services, 2017
  • Figure 04: Global Particle Therapy Market Value Share, by End-user, 2017
  • Figure 05: Global Particle Therapy Market Value Share, by Region, 2017
  • Figure 06: Global Particle Therapy Market Value Share, by Therapy, 2018 and 2026
  • Figure 07: Global Particle Therapy Market Attractiveness, by Therapy, 2018-2026
  • Figure 08: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Proton Therapy, 2016-2026
  • Figure 09: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Carbon Therapy, 2016-2026
  • Figure 10: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Other Therapy, 2016-2026
  • Figure 11: Global Particle Therapy Market Value Share, by Cancer Application, 2018 and 2026
  • Figure 12: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pediatric Cancer, 2016-2026
  • Figure 13: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lung Cancer, 2016-2026
  • Figure 14: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Bladder Cancer, 2016-2026
  • Figure 15: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Brain and Spinal Cord Tumors (BSCT), 2016-2026
  • Figure 16: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Breast Cancer, 2016-2026
  • Figure 17: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Gastrointestinal (GI) Cancers, 2016-2026
  • Figure 18: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hepatocellular Carcinoma (HCC), 2016-2026
  • Figure 19: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Head and Neck Cancers (HNC), 2016-2026
  • Figure 20: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Other Cancers, 2016-2026
  • Figure 21: Global Particle Therapy Market Attractiveness, by Cancer Application, 2018-2026
  • Figure 22: Global Particle Therapy Market Value Share, by Services, 2018 and 2026
  • Figure 23: Global Particle Therapy Market Attractiveness, by Services, 2018-2026
  • Figure 24: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cyclotrons, 2016-2026
  • Figure 25: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Synchrotrons, 2016-2026
  • Figure 26: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Synchrocyclotrons, 2016-2026
  • Figure 27: Global Particle Therapy Market Value Share, by End-user, 2018 and 2026
  • Figure 28: Global Particle Therapy Market Attractiveness, by End-user, 2018-2026
  • Figure 29: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2016-2026
  • Figure 30: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Specialty Clinics, 2016-2026
  • Figure 31: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ambulatory Surgical Centers, 2016-2026
  • Figure 32: Global Particle Therapy Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016-2026
  • Figure 33: Global Particle Therapy Market Value Share, by Region, 2018 and 2026
  • Figure 34: Global Particle Therapy Market Attractiveness, by Region, 2018-2026
  • Figure 35: North America Particle Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 36: North America Particle Therapy Market Value Share, by Country, 2018-2026
  • Figure 37: North America Particle Therapy Market Attractiveness, by Country, 2018-2026
  • Figure 38: North America Particle Therapy Market Value Share, by Therapy, 2018 and 2026
  • Figure 39: North America Particle Therapy Market Attractiveness, by Therapy, 2018-2026
  • Figure 40: North America Particle Therapy Market Value Share, by Services, 2018 and 2026
  • Figure 41: North America Particle Therapy Market Attractiveness, by Services, 2018-2026
  • Figure 42: North America Particle Therapy Market Value Share, by End-user, 2018 and 2026
  • Figure 43: North America Particle Therapy Market Attractiveness, by End-user, 2018-2026
  • Figure 44: North America Particle Therapy Market Value Share, by Cancer Application, 2018 and 2026
  • Figure 45: North America Particle Therapy Market Attractiveness, by Cancer Application, 2018-2026
  • Figure 46: Europe Particle Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 47: Europe Particle Therapy Market Value Share, by Country/Sub-Region, 2018-2026
  • Figure 48: Europe Particle Therapy Market Attractiveness, by Country/Sub-Region, 2018-2026
  • Figure 49: Europe Particle Therapy Market Value Share, by Therapy, 2018 and 2026
  • Figure 50: Europe Particle Therapy Market Attractiveness, by Therapy, 2018-2026
  • Figure 51: Europe Particle Therapy Market Value Share, by Services, 2018 and 2026
  • Figure 52: Europe Particle Therapy Market Attractiveness, by Services, 2018-2026
  • Figure 53: Europe Particle Therapy Market Value Share, by End-user, 2018 and 2026
  • Figure 54: Europe Particle Therapy Market Attractiveness, by End-user, 2018-2026
  • Figure 55: Europe Particle Therapy Market Value Share, by Cancer Application, 2018 and 2026
  • Figure 56: Europe Particle Therapy Market Attractiveness, by Cancer Application, 2018-2026
  • Figure 57: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 58: Asia Pacific Particle Therapy Market Value Share, by Country/Sub-Region, 2018-2026
  • Figure 59: Asia Pacific Particle Therapy Market Attractiveness, by Country, 2018-2026
  • Figure 60: Asia Pacific Particle Therapy Market Value Share, by Therapy, 2018 and 2026
  • Figure 61: Asia Pacific Particle Therapy Market Attractiveness, by Therapy, 2018-2026
  • Figure 62: Asia Pacific Particle Therapy Market Value Share, by Services, 2018 and 2026
  • Figure 63: Asia Pacific Particle Therapy Market Attractiveness, by Services, 2018-2026
  • Figure 64: Asia Pacific Particle Therapy Market Value Share, by End-user, 2018 and 2026
  • Figure 65: Asia Pacific Particle Therapy Market Attractiveness, by End-user, 2018-2026
  • Figure 66: Asia Pacific Particle Therapy Market Value Share, by Cancer Application, 2018 and 2026
  • Figure 67: Asia Pacific Particle Therapy Market Attractiveness, by Cancer Application, 2018-2026
  • Figure 68: Latin America Particle Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 69: Latin America Particle Therapy Market Value Share, by Country/Sub-Region, 2018-2026
  • Figure 70: Latin America Particle Therapy Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 71: Latin America Particle Therapy Market Value Share, by Therapy, 2018 and 2026
  • Figure 72: Latin America Particle Therapy Market Attractiveness, by Therapy, 2018-2026
  • Figure 73: Latin America Particle Therapy Market Value Share, by Services, 2018 and 2026
  • Figure 74: Latin America Particle Therapy Market Attractiveness, by Services, 2018-2026
  • Figure 75: Latin America Particle Therapy Market Value Share, by End-user, 2018 and 2026
  • Figure 76: Latin America Particle Therapy Market Attractiveness, by End-user, 2018-2026
  • Figure 77: Latin America Particle Therapy Market Value Share, by Cancer Application, 2018 and 2026
  • Figure 78: Latin America Particle Therapy Market Attractiveness, by Cancer Application, 2018-2026
  • Figure 79: Middle East & Africa Particle Therapy Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016-2026
  • Figure 80: Middle East & Africa Particle Therapy Market Value Share, by Country/Sub-region, 2018 and 2026
  • Figure 81: Middle East & Africa Particle Therapy Market Attractiveness, by Country/Sub-region, 2018-2026
  • Figure 82: Middle East & Africa Particle Therapy Market Value Share, by Therapy, 2018 and 2026
  • Figure 83: Middle East & Africa Particle Therapy Market Attractiveness, by Therapy, 2018-2026
  • Figure 84: Middle East & Africa Particle Therapy Market Value Share, by Services, 2018 and 2026
  • Figure 85: Middle East & Africa Particle Therapy Market Attractiveness, by Services, 2018-2026
  • Figure 86: Middle East & Africa Particle Therapy Market Value Share, by End-user, 2018 and 2026
  • Figure 87: Middle East & Africa Particle Therapy Market Attractiveness, by End-user, 2018-2026
  • Figure 88: Middle East & Africa Particle Therapy Market Value Share, by Cancer Application, 2018 and 2026
  • Figure 89: Middle East & Africa Particle Therapy Market Attractiveness, by Cancer Application, 2018-2026
  • Figure 90: Global Particle Therapy Market Share, by Company, 2017
目次

Title:
Particle Therapy Market (Therapy - Proton Therapy, Carbon Therapy, Other Therapy; Cancer Application - Pediatric Cancer, Lung Cancer, Bladder Cancer, Brain and Spinal Cord Tumors (BSCT), Breast Cancer, Gastrointestinal (GI) Cancers, Hepatocellular Carcinoma (HCC), Head and Neck Cancers (HNC); Services - Cyclotrons, Synchrotrons, Synchrocyclotrons; End user - Hospitals, Specialty Clinics, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.

Particle Therapy Market - Overview

This report on the particle therapy market analyzes the current and future scenario of the global market. Large number of cancer patients opting for particle therapy and incidences of brain tumor occurrence among the geriatric population are boosting the usage of proton and carbon therapy. Less pain and high definition healing technology are major drivers of the global particle therapy market.

The particle therapy market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on services, therapy, cancer application, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. Additionally, the section comprises major player's product portfolio-based on technology & cancer application to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global particle therapy market.

Based on therapy, the market has been segmented into proton therapy, carbon therapy, and other therapy. The therapy segment has been analyzed based on available centers providing particle therapy, cost-effectiveness, and preference for therapy by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Based on services, the market has been segmented into cyclotrons, synchrotrons, and synchrocyclotrons. The therapy segment has been analyzed based on available centers established with different services in different regions/country, cost-effectiveness, and preference for therapy by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Based on end-user, the particle therapy market has been classified into hospitals, specialty clinics, ambulatory surgical centers, and others. The particle therapy market has also been segmented based on the application of particle therapy for cancer treatment. The market segments have been extensively analyzed based on prevalence of the diseases, available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2018 to 2026, considering 2017 as the base year.

In terms of region, the global particle therapy market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, Russia, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the global particle therapy market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Varian Medical Systems, Inc., Hitachi, Ltd., IBA Worldwide, Sumitomo Heavy Industries, Ltd., Advanced Oncotherapy PLC., Mevion Medical Systems, Inc., Provision Healthcare, LLC, Optivus Proton Therapy, Inc., Protom International, Inc., and Danfysik A/S.

The global particle therapy market has been segmented as given below:

Global Particle Therapy Market, by Therapy

  • Proton Therapy
  • Carbon Therapy
  • Other Therapy

Global Particle Therapy Market, by Cancer Application

  • Pediatric Cancer
  • Lung Cancer
  • Bladder Cancer
  • Brain and Spinal Cord Tumors (BSCT)
  • Breast Cancer
  • Gastrointestinal (GI) Cancers
  • Hepatocellular Carcinoma (HCC)
  • Head and Neck Cancers (HNC)
  • Others

Global Particle Therapy Market, by Services

  • Cyclotrons
  • Synchrotrons
  • Synchrocyclotrons

Global Particle Therapy Market, by End-user

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

Global Particle Therapy Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC countries
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Particle Therapy Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Particle Therapy Market Analysis and Forecast, 2016-2026
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Market Outlook
  • 4.6. Regulatory Scenarios
  • 4.7. Particle therapy facilities in clinical operation, 2017
  • 4.8. Pricing Analysis, 2017

5. Global Particle Therapy Market Analysis and Forecast, by Therapy

  • 5.1. Introduction & Definition
  • 5.2. Key Findings / Developments
  • 5.3. Global Particle Therapy Market Forecast, by Therapy, 2016-2026
    • 5.3.1. Photon Therapy
    • 5.3.2. Carbon Therapy
    • 5.3.3. Other Therapy
  • 5.4. Global Particle Therapy Market Attractiveness, by Therapy

6. Global Particle Therapy Market Analysis and Forecast, by Cancer Application

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Particle Therapy Market Forecast, by Cancer Application, 2016-2026
    • 6.3.1. Pediatric Cancer
    • 6.3.2. Lung Cancer
    • 6.3.3. Bladder Cancer
    • 6.3.4. Brain and Spinal Cord Tumors (BSCT)
    • 6.3.5. Breast Cancer
    • 6.3.6. Gastrointestinal (GI) Cancers
    • 6.3.7. Hepatocellular Carcinoma (HCC)
    • 6.3.8. Head and Neck Cancers (HNC)
    • 6.3.9. Others
  • 6.4. Global Particle Therapy Market Attractiveness, by Cancer Application

7. Global Particle Therapy Market Analysis and Forecast, by Services

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Global Particle Therapy Market Forecast, by Services, 2016-2026
    • 7.3.1. Cyclotrons
    • 7.3.2. Synchrotrons
    • 7.3.3. Synchrocyclotrons
  • 7.4. Global Particle Therapy Market Attractiveness, by Services

8. Global Particle Therapy Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Global Particle Therapy Market Forecast, by End-user, 2016-2026
    • 8.3.1. Hospitals
    • 8.3.2. Specialty Clinics
    • 8.3.3. Ambulatory Surgical Centers
    • 8.3.4. Others
  • 8.4. Global Particle Therapy Market Attractiveness, by End-user

9. Global Particle Therapy Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Global Particle Therapy Market Attractiveness, by Region

10. North America Particle Therapy Market Analysis and Forecast

10.1.Introduction

    • 10.1.1. Key Findings
  • 10.2. North America Particle Therapy Market Forecast, by Therapy, 2016-2026
    • 10.2.1. Photon Therapy
    • 10.2.2. Carbon Therapy
    • 10.2.3. Other Therapy
  • 10.3. North America Particle Therapy Market Forecast, by Cancer Application, 2016-2026
    • 10.3.1. Pediatric Cancer
    • 10.3.2. Lung Cancer
    • 10.3.3. Bladder Cancer
    • 10.3.4. Brain and Spinal Cord Tumors (BSCT)
    • 10.3.5. Breast Cancer
    • 10.3.6. Gastrointestinal (GI) Cancers
    • 10.3.7. Hepatocellular Carcinoma (HCC)
    • 10.3.8. Head and Neck Cancers (HNC)
    • 10.3.9. Others
  • 10.4. North America Particle Therapy Market Forecast, by Services, 2016-2026
    • 10.4.1. Cyclotrons
    • 10.4.2. Synchrotrons
    • 10.4.3. Synchrocyclotrons
  • 10.5. North America Particle Therapy Market Forecast, by End-user, 2016-2026
    • 10.5.1. Hospitals
    • 10.5.2. Specialty Clinics
    • 10.5.3. Ambulatory Surgical Centers
    • 10.5.4. Others
  • 10.6. North America Particle Therapy Market Forecast, by Country, 2016-2026
    • 10.6.1. U.S.
    • 10.6.2. Canada
  • 10.7. North America Particle Therapy Market Attractiveness Analysis
    • 10.7.1. By Therapy
    • 10.7.2. By Cancer Application
    • 10.7.3. By Services
    • 10.7.4. By End-user
    • 10.7.5. By Country

11. Europe Particle Therapy Market Analysis and Forecast

11.1.Introduction

    • 11.1.1. Key Findings
  • 11.2. Europe Particle Therapy Market Forecast, by Therapy, 2016-2026
    • 11.2.1. Photon Therapy
    • 11.2.2. Carbon Therapy
    • 11.2.3. Other Therapy
  • 11.3. Europe Particle Therapy Market Forecast, by Cancer Application, 2016-2026
    • 11.3.1. Pediatric Cancer
    • 11.3.2. Lung Cancer
    • 11.3.3. Bladder Cancer
    • 11.3.4. Brain and Spinal Cord Tumors (BSCT)
    • 11.3.5. Breast Cancer
    • 11.3.6. Gastrointestinal (GI) Cancers
    • 11.3.7. Hepatocellular Carcinoma (HCC)
    • 11.3.8. Head and Neck Cancers (HNC)
    • 11.3.9. Others
  • 11.4. Europe Particle Therapy Market Forecast, by Services, 2016-2026
    • 11.4.1. Cyclotrons
    • 11.4.2. Synchrotrons
    • 11.4.3. Synchrocyclotrons
  • 11.5. Europe Particle Therapy Market Forecast, by End-user, 2016-2026
    • 11.5.1. Hospitals
    • 11.5.2. Specialty Clinics
    • 11.5.3. Ambulatory Surgical Centers
    • 11.5.4. Others
  • 11.6. Europe Particle Therapy Market Forecast, by Country/Sub-region, 2016-2026
    • 11.6.1. Germany
    • 11.6.2. U.K.
    • 11.6.3. France
    • 11.6.4. Spain
    • 11.6.5. Italy
    • 11.6.6. Rest of Europe
  • 11.7. Europe Particle Therapy Market Attractiveness Analysis
    • 11.7.1. By Therapy
    • 11.7.2. By Cancer Application
    • 11.7.3. By Services
    • 11.7.4. By End-user
    • 11.7.5. By Country/Sub-region

12. Asia Pacific Particle Therapy Market Analysis and Forecast

12.1.Introduction

    • 12.1.1. Key Findings
  • 12.2. Asia Pacific Particle Therapy Market Forecast, by Therapy, 2016-2026
    • 12.2.1. Photon Therapy
    • 12.2.2. Carbon Therapy
    • 12.2.3. Other Therapy
  • 12.3. Asia Pacific Particle Therapy Market Forecast, by Cancer Application, 2016-2026
    • 12.3.1. Pediatric Cancer
    • 12.3.2. Lung Cancer
    • 12.3.3. Bladder Cancer
    • 12.3.4. Brain and Spinal Cord Tumors (BSCT)
    • 12.3.5. Breast Cancer
    • 12.3.6. Gastrointestinal (GI) Cancers
    • 12.3.7. Hepatocellular Carcinoma (HCC)
    • 12.3.8. Head and Neck Cancers (HNC)
    • 12.3.9. Others
  • 12.4. Asia Pacific Particle Therapy Market Forecast, by Services, 2016-2026
    • 12.4.1. Cyclotrons
    • 12.4.2. Synchrotrons
    • 12.4.3. Synchrocyclotrons
  • 12.5. Asia Pacific Particle Therapy Market Forecast, by End-user, 2016-2026
    • 12.5.1. Hospitals
    • 12.5.2. Specialty Clinics
    • 12.5.3. Ambulatory Surgical Centers
    • 12.5.4. Others
  • 12.6. Asia Pacific Particle Therapy Market Forecast, by Country/Sub-region, 2016-2026
    • 12.6.1. China
    • 12.6.2. Japan
    • 12.6.3. India
    • 12.6.4. Australia & New Zealand
    • 12.6.5. Rest of Asia Pacific
  • 12.7. Asia Pacific Particle Therapy Market Attractiveness Analysis
    • 12.7.1. By Therapy
    • 12.7.2. By Cancer Application
    • 12.7.3. By Services
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Latin America Particle Therapy Market Analysis and Forecast

13.1.Introduction

    • 13.1.1. Key Findings
  • 13.2. Latin America Particle Therapy Market Forecast, by Therapy, 2016-2026
    • 13.2.1. Photon Therapy
    • 13.2.2. Carbon Therapy
    • 13.2.3. Other Therapy
  • 13.3. Latin America Particle Therapy Market Forecast, by Cancer Application, 2016-2026
    • 13.3.1. Pediatric Cancer
    • 13.3.2. Lung Cancer
    • 13.3.3. Bladder Cancer
    • 13.3.4. Brain and Spinal Cord Tumors (BSCT)
    • 13.3.5. Breast Cancer
    • 13.3.6. Gastrointestinal (GI) Cancers
    • 13.3.7. Hepatocellular Carcinoma (HCC)
    • 13.3.8. Head and Neck Cancers (HNC)
    • 13.3.9. Others
  • 13.4. Latin America Particle Therapy Market Forecast, by Services, 2016-2026
    • 13.4.1. Cyclotrons
    • 13.4.2. Synchrotrons
    • 13.4.3. Synchrocyclotrons
  • 13.5. Latin America Particle Therapy Market Forecast, by End-user, 2016-2026
    • 13.5.1. Hospitals
    • 13.5.2. Specialty Clinics
    • 13.5.3. Ambulatory Surgical Centers
    • 13.5.4. Others
  • 13.6. Latin America Particle Therapy Market Forecast, by Country/Sub-region, 2016-2026
    • 13.6.1. Brazil
    • 13.6.2. Mexico
    • 13.6.3. Rest of Latin America
  • 13.7. Latin America Particle Therapy Market Attractiveness Analysis
    • 13.7.1. By Therapy
    • 13.7.2. By Cancer Application
    • 13.7.3. By Services
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Middle East & Africa Particle Therapy Market Analysis and Forecast

14.1.Introduction

    • 14.1.1. Key Findings
  • 14.2. Middle East & Africa Particle Therapy Market Forecast, by Therapy, 2016-2026
    • 14.2.1. Photon Therapy
    • 14.2.2. Carbon Therapy
    • 14.2.3. Other Therapy
  • 14.3. Middle East & Africa Particle Therapy Market Forecast, by Cancer Application, 2016-2026
    • 14.3.1. Pediatric Cancer
    • 14.3.2. Lung Cancer
    • 14.3.3. Bladder Cancer
    • 14.3.4. Brain and Spinal Cord Tumors (BSCT)
    • 14.3.5. Breast Cancer
    • 14.3.6. Gastrointestinal (GI) Cancers
    • 14.3.7. Hepatocellular Carcinoma (HCC)
    • 14.3.8. Head and Neck Cancers (HNC)
    • 14.3.9. Others
  • 14.4. Middle East & Africa Particle Therapy Market Forecast, by Services, 2016-2026
    • 14.4.1. Cyclotrons
    • 14.4.2. Synchrotrons
    • 14.4.3. Synchrocyclotrons
  • 14.5. Middle East & Africa Particle Therapy Market Forecast, by End-user, 2016-2026
    • 14.5.1. Hospitals
    • 14.5.2. Specialty Clinics
    • 14.5.3. Ambulatory Surgical Centers
    • 14.5.4. Others
  • 14.6. Middle East & Africa Particle Therapy Market Forecast, by Country/Sub-region, 2016-2026
    • 14.6.1. GCC countries
    • 14.6.2. South Africa
    • 14.6.3. Rest of Middle East & Africa
  • 14.7. Middle East & Africa Particle Therapy Market Attractiveness Analysis
    • 14.7.1. By Therapy
    • 14.7.2. By Cancer Application
    • 14.7.3. By Services
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Competition Landscape

15.1.Market Player - Competition Matrix (By Tier and Size of companies)

15.2.Market Share Analysis By Company (2017)

15.3.Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)

    • 15.3.1. Varian Medical Systems, Inc.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Financial Overview
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Hitachi, Ltd.
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Financial Overview
      • 15.3.2.5. Strategic Overview
    • 15.3.3. IBA Worldwide
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Financial Overview
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Advanced Oncotherapy PLC.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Financial Overview
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Mevion Medical Systems, Inc.
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Financial Overview
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Danfysik A/S
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Financial Overview
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Sumitomo Heavy Industries, Ltd.
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Financial Overview
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Optivus Proton Therapy, Inc.
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Financial Overview
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Protom International, Inc.
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Financial Overview
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Others
Back to Top